This is list of CBD clinical trials – how CBD may affect various conditions. Trial lists are for both both active and pending CBD clinical trials.

Active Clinical Trials

 

Pending Clinical Trials

Cannabidiol as a Treatment for Alcohol Use Disorder Comorbid With Posttraumatic Stress Disorder

Estimated start date: 11/15/2018 | Estimated end date: 08/31/2019

This project aims to determine whether cannabidiol (CBD), a compound derived from the cannabis plant, is effective in treating alcohol use disorder (AUD) in individuals with comorbid posttraumatic stress disorder (PTSD). Investigators will test the hypothesis that oral cannabidiol (CBD) will reduce alcohol drinking in individuals with AUD comorbid with PTSD. To test this hypothesis, 50 otherwise healthy adult participants with moderate or severe AUD and PTSD will be randomized to treatment with either CBD (400 mg daily) or placebo, for a period of 6 weeks, such that both participants and study staff are blind to treatment condition.

comorbidity: the simultaneous presence of two chronic diseases or conditions in a patient.

Associated conditions: PTSD, Alcoholism

Eligible Sexes: All sexes

Eligible Ages: From 18 and above

Number of participants: 50 enrollees

Healthy participants allowed: Not Allowed

Location: New York, New York

Contact for information:

  • Name: Duna Abu-amara, MPH

  • Phone: 646 754 4793

  • Email: Duna.Abu-amara@nyumc.org

Sponsor of the clinical trial: New York University School of Medicine

Get more information: Link to clinical trial